Time for a Paradigm Shift in Immunotherapy-Based BCMA/CD3 Bispecific Drug Development in Multiple Myeloma
Leukemia（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined